OT
OCON Therapeutics
About
OCON Therapeutics innovates, develops, manufactures, and commercializes cutting-edge women’s health products based on our patented IUB® (Intra Uterine Ball) proprietary platform. The IUB® made from a super-elastic alloy Nitinol, is an ideal carrier for multiple drugs to the uterus to treat a variety of conditions.
Tags
Total Employees
34
Current headcount
Company Timeline
Funding rounds, employee growth, revenue, and exits over the same period. News mentions shown as markers.
No timeline data for this period
Score Breakdown
35Traction
51Team
30Visibility
8Profile
65Community
0Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does OCON Therapeutics do?
OCON Therapeutics innovates, develops, manufactures, and commercializes cutting-edge women’s health products based on our patented IUB® (Intra Uterine Ball) proprietary platform. The IUB® made from a super-elastic alloy Nitinol, is an ideal carrier for multiple drugs to the uterus to treat a variety of conditions.
How much funding has OCON Therapeutics raised?
OCON Therapeutics has raised a total of $12M in funding. The most recent round on record is Seed.
When was OCON Therapeutics founded?
OCON Therapeutics was founded in 2011.
What industry does OCON Therapeutics operate in?
OCON Therapeutics operates in Healthcare, Medical Device, FemTech, Drug Delivery.
How many employees does OCON Therapeutics have?
OCON Therapeutics has approximately 34 people on record.